[go: up one dir, main page]

BR9911887A - Método para o tratamento da insÈnia - Google Patents

Método para o tratamento da insÈnia

Info

Publication number
BR9911887A
BR9911887A BR9911887-4A BR9911887A BR9911887A BR 9911887 A BR9911887 A BR 9911887A BR 9911887 A BR9911887 A BR 9911887A BR 9911887 A BR9911887 A BR 9911887A
Authority
BR
Brazil
Prior art keywords
treating insomnia
insomnia
treating
insignia
gamma
Prior art date
Application number
BR9911887-4A
Other languages
English (en)
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR9911887A publication Critical patent/BR9911887A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"MéTODO PARA O TRATAMENTO DA INSÈNIA"<D>. A presente invenção é um método de utilização de certos análogos de ácido glutâmico e de ácido gama-aminobutírico para o tratamento da insónia.
BR9911887-4A 1998-07-09 1999-07-01 Método para o tratamento da insÈnia BR9911887A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9216698P 1998-07-09 1998-07-09
PCT/US1999/015058 WO2000002546A2 (en) 1998-07-09 1999-07-01 Use of caba-analogues for treating insomnia

Publications (1)

Publication Number Publication Date
BR9911887A true BR9911887A (pt) 2001-03-27

Family

ID=22231954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911887-4A BR9911887A (pt) 1998-07-09 1999-07-01 Método para o tratamento da insÈnia

Country Status (13)

Country Link
US (2) US6306910B1 (pt)
EP (1) EP1094803A2 (pt)
JP (1) JP2002520277A (pt)
KR (1) KR20010071778A (pt)
AU (1) AU765038B2 (pt)
BR (1) BR9911887A (pt)
CA (1) CA2333024C (pt)
ID (1) ID27191A (pt)
NO (1) NO20010117L (pt)
NZ (1) NZ509231A (pt)
PL (1) PL345338A1 (pt)
WO (1) WO2000002546A2 (pt)
ZA (1) ZA200007174B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
US20080207755A1 (en) * 2000-05-31 2008-08-28 Pfizer Inc Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
US7164034B2 (en) * 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
BR0111913A (pt) * 2000-06-26 2004-01-06 Warner Lambert Co Análogos de gabapentina para distúrbios do sono
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
US7071339B2 (en) * 2002-08-29 2006-07-04 Warner Lambert Company Llc Process for preparing functionalized γ-butyrolactones from mucohalic acid
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
CA2509615A1 (en) * 2002-12-13 2004-07-01 Warner-Lambert Company Llc Gabapentin analogues for fibromyalgia and other related disorders
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
AU2003286300A1 (en) * 2002-12-13 2004-07-09 Warner-Lambert Company Llc Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
CA2505788A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
RU2335342C2 (ru) * 2004-03-12 2008-10-10 Уорнер-Ламберт Компани Ллс C1-симметричные бисфосфиновые лиганды и их применение в асимметрическом синтезе прегабалина
JP4504063B2 (ja) * 2004-03-30 2010-07-14 エスエス製薬株式会社 睡眠改善薬
CA2561755A1 (en) * 2004-04-01 2005-10-13 Warner-Lambert Company Llc Preparation of p-chirogenic phospholanes and their use in asymmetric synthesis
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
KR100847929B1 (ko) * 2004-06-21 2008-07-22 워너-램버트 캄파니 엘엘씨 프레가발린 및 관련 화합물의 제조방법
WO2006041158A1 (ja) * 2004-10-14 2006-04-20 Daikin Industries, Ltd. 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
KR100606103B1 (ko) * 2005-07-15 2006-07-31 삼성전자주식회사 서로 다른 통신망 간의 ｐｓ호의 핸드오버 방법 및 이를 위한 듀얼모드 단말기
BRPI0720252A2 (pt) * 2006-12-08 2014-01-07 Xenoport Inc Uso de pró-fármacos de análogos de gaba para tratar doenças
EP2285365A4 (en) * 2007-08-03 2011-02-23 Soeren Tullin USE OF A COMPOSITION COMPRISING AT LEAST ONE BETABILITY TREATMENT FOR THE TREATMENT OF SLEEP DISORDERS
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder

Also Published As

Publication number Publication date
US6306910B1 (en) 2001-10-23
ZA200007174B (en) 2002-03-04
WO2000002546A2 (en) 2000-01-20
NO20010117D0 (no) 2001-01-08
KR20010071778A (ko) 2001-07-31
WO2000002546A3 (en) 2000-06-15
US20020004528A1 (en) 2002-01-10
AU765038B2 (en) 2003-09-04
AU4967399A (en) 2000-02-01
CA2333024C (en) 2002-03-26
NZ509231A (en) 2003-08-29
EP1094803A2 (en) 2001-05-02
PL345338A1 (en) 2001-12-17
NO20010117L (no) 2001-01-08
CA2333024A1 (en) 2000-01-20
JP2002520277A (ja) 2002-07-09
ID27191A (id) 2001-03-08

Similar Documents

Publication Publication Date Title
BR9911887A (pt) Método para o tratamento da insÈnia
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
BR0113520A (pt) Processo de preparação de ácidos n-aril-antranìlicos e seus derivados
ATE374029T1 (de) Behandlung der alzheimer-krankheit durch erhöhung des cytidin-spiegels in vivo
MX9806069A (es) Novedosos amino acidos ciclicos substituidos como agentes farmaceuticos.
ATE280154T1 (de) Verzweigte alkylpyrrolidin-3-carbonsäuren
DK0888325T3 (da) Cykliske aminosyrer som farmaceutiske midler
IL128877A0 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer&#39;s disease and dementias
DE122005000043I1 (de) Zusammensetzungen zur Erzielung von analgesie und zur Hemmung der Progression neuropatisher Schmerz erkrankungen
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
DE69611598D1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DE60044160D1 (de) Behandlung von Inkontinenz
BR0012058A (pt) Combinação sinérgica: gabapentina e pregabalina
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR9915434A (pt) Derivados anticonvulsivos úteis no tratamento dedistúrbio de estresse pós-traumático
BR9712773A (pt) Processo para a sìntese de benzotiofenos
DE69921137D1 (de) Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
BR9809439A (pt) Processos para preparação de benzotiofenos
BR9911943A (pt) Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino
BR9712805A (pt) Processo para a preparação de compostos farmecêuticos
BR9911925A (pt) O tratamento de cólica renal com análogos de gaba
BR9812265A (pt) Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.